OCM
PRAX icon

Ovata Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Ovata Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,777
Closed -$563K – 37
2024
Q3 		$563K Sell
9,777
-30,223
-76% -$1.63M 0.24% 25
2024
Q2 		$1.65M Buy
40,000
+20,000
+100% +$945K 0.9% 21
2024
Q1 		$1.22M Buy
+20,000
New +$897K 0.64% 25

Other funds holding PRAX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ovata Capital Management's PRAX Position: Q4 2024 in Review

Ovata Capital Management sold out of Praxis Precision Medicines (PRAX) in Q4 2024, closing a stake of 9,777 shares — an estimated $563K sold.

Ovata Capital Management first reported a position in PRAX in Q1 2024 and held it in 3 quarters. The position peaked at $1.65M in Q2 2024. 162 funds tracked by Wall St. Rank hold PRAX as of Q4 2024.

  • Ovata Capital Management reported no remaining Praxis Precision Medicines position as of Q4 2024 after selling out during the quarter.
  • Ovata Capital Management sold 9,777 Praxis Precision Medicines shares in Q4 2024, an estimated $563K.
  • Ovata Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 3 quarters.
  • Ovata Capital Management's Praxis Precision Medicines position peaked at $1.65M in Q2 2024.
  • 162 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2024.

Based on Ovata Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.